Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.
Dan-Qian ChenGang CaoHui ZhaoLin ChenTian YangMing WangNosratola D VaziriYan GuoYing-Yong ZhaoPublished in: Therapeutic advances in chronic disease (2019)
Combined melatonin and PAA provides a promising therapeutic strategy to treat renal fibrosis during the AKI-to-CKD continuum.